Protection from pulmonary ischemia-reperfusion injury by adenosine A2A receptor activation
TLDR
Specific activation of A2AARs provides potent protection against lung IR injury via attenuation of inflammation, and occurs in the absence of circulating blood thereby indicating a protective role of A 2AAR activation on resident lung cells such as alveolar macrophages.Abstract:
Background: Lung ischemia-reperfusion (IR) injury leads to significant morbidity and mortality which remains a major obstacle after lung transplantation. However, the role of various subset(s) of lung cell populations in the pathogenesis of lung IR injury and the mechanisms of cellular protection remain to be elucidated. In the present study, we investigated the effects of adenosine A 2A receptor (A 2A AR) activation on resident lung cells after IR injury using an isolated, bufferperfused murine lung model. Methods: To assess the protective effects of A2AAR activation, three groups of C57BL/6J mice were studied: a sham group (perfused for 2 hr with no ischemia), an IR group (1 hr ischemia + 1 hr reperfusion) and an IR+ATL313 group where ATL313, a specific A 2A AR agonist, was included in the reperfusion buffer after ischemia. Lung injury parameters and pulmonary function studies were also performed after IR injury in A2AAR knockout mice, with or without ATL313 pretreatment. Lung function was assessed using a buffer-perfused isolated lung system. Lung injury was measured by assessing lung edema, vascular permeability, cytokine/chemokine activation and myeloperoxidase levels in the bronchoalveolar fluid. Results: After IR, lungs from C57BL/6J wild-type mice displayed significant dysfunction (increased airway resistance, pulmonary artery pressure and decreased pulmonary compliance) and significant injury (increased vascular permeability and edema). Lung injury and dysfunction after IR were significantly attenuated by ATL313 treatment. Significant induction of TNF-α, KC (CXCL1), MIP-2 (CXCL2) and RANTES (CCL5) occurred after IR which was also attenuated by ATL313 treatment. Lungs from A2AAR knockout mice also displayed significant dysfunction, injury and cytokine/ chemokine production after IR, but ATL313 had no effect in these mice. Conclusion: Specific activation of A 2A ARs provides potent protection against lung IR injury via attenuation of inflammation. This protection occurs in the absence of circulating blood thereby indicating a protective role of A2AAR activation on resident lung cells such as alveolar macrophages. Specific A 2A AR activation may be a promising therapeutic target for the prevention or treatment of pulmonary graft dysfunction in transplant patients.read more
Citations
More filters
Book ChapterDOI
Lung Transplantation and the Blood–Gas Barrier
Anke Schnapper,Matthias Ochs +1 more
TL;DR: To increase the rate of transplantable donor organs, very promising results are achieved by the new technique of ex vivo lung perfusion (EVLP), and beyond the immediate transplantation period, the BGB is jeopardized in certain forms of acute rejection and chronic lung allograft dysfunction.
Posted ContentDOI
KD-64 - a new selective A2A adenosine receptor antagonist has anti-inflammatory activity but contrary to the non-selective antagonist - caffeine does not reduce diet-induced obesity in mice
Magdalena Kotańska,Anna Dziubina,Małgorzata Szafarz,Kamil Mika,Karolina Reguła,Marek Bednarski,Małgorzata Zygmunt,Anna Drabczyńska,Jacek Sapa,Katarzyna Kieć-Kononowicz +9 more
TL;DR: Although, contrary to caffeine, KD-64 did not reduce diet-induced obesity in mice, it improved glucose tolerance and the activity of the selective adenosine A2A receptor antagonist was quite different from that of the non-selective.
Journal ArticleDOI
Regadenoson to the rescue: On the road toward prevention of primary graft dysfunction after lung transplantation
Journal ArticleDOI
Fundamentals and Applications of Isolated Perfused Lung (IPL) Model in the Development of Pulmonary Drug Delivery.
Katayoon Mireskandari,Yalda H. Ardakani,Ebrahim Saeedian Moghadam,Farzaneh Ketabchi,Mohammad-Reza Rouini +4 more
TL;DR: The use of the isolated perfused lung model (IPL) has become more common, and it is considered a useful tool to increase understanding in this area since it offers the possibility of controlling the administration and easier sampling of perfusate and lavage fluid.
References
More filters
Journal ArticleDOI
Ischemia-reperfusion-induced lung injury.
TL;DR: Better understanding of the mechanisms of ischemia-reperfusion injury, improvements in the technique of lung preservation, and the development of a new preservation solution specifically for the lung have been associated with a reduction in the incidence of primary graft failure from approximately 30 to 15% or less.
Journal ArticleDOI
Molecular Approach to Adenosine Receptors: Receptor-Mediated Mechanisms of Tissue Protection
TL;DR: Novel adenosine receptor subtype-selective ligands have recently been developed that will help investigators to sort out how adenoine protects tissues from injury and to identify new therapeutic agents that hold promise for the treatment of inflammatory and ischemic diseases.
Journal ArticleDOI
Adenosine, an endogenous anti-inflammatory agent.
TL;DR: The observations reviewed here suggest that adenosine and agents that act throughadenosine are excellent candidates for development as anti-inflammatory agents.
Journal ArticleDOI
Pulmonary atelectasis: a pathogenic perioperative entity.
TL;DR: The authors discuss the effects and implications of atelectasis in the perioperative period and illustrate how preventive measures may impact outcome and the impact of atElectasis and its prevention in acute lung injury.
Journal ArticleDOI
Obliterative bronchiolitis after lung and heart-lung transplantation: An analysis of risk factors and management
Ko Bando,Irvin L. Paradis,Shari L. Similo,Hiroaki Konishi,Kanshi Komatsu,Thomas G. Zullo,Samuel A. Yousem,John M. Close,Adriana Zeevi,Rene J. Duquesnoy,Jan D. Manzetti,Robert J. Keenan,John M. Armitage,Robert L. Hardesty,Bartley P. Griffith +14 more
TL;DR: Recipients with obliterative bronchiolitis detected in the preclinical stage were significantly more likely to be in remission than recipients who had clinical disease at the time of diagnosis and results indicate that acute rejection is the most significant risk factor for development of obliteration and that obliteration responds to treatment with augmented immunosuppression when it is detected early by surveillance transbronchial biopsy.
Related Papers (5)
Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage.
Akio Ohta,Michail V. Sitkovsky +1 more